Neuraxpharm

New video release: Peace of Mind - Overcoming Anxiety. What's it like to see a psychologist for anxiety?   As part of our ongoing campaign, “Peace of Mind: Raising Awareness on Anxiety”, we present a new video featuring Clinical Psychologist Dr. Yasmine Lau. In this insightful video, Dr. Lau discusses several types of psychotherapy, such as cognitive behavioural therapy or talking therapy, that can help manage symptoms of anxiety. This campaign is a collaborative effort between #Neuraxpharm and Maudsley Learning, created to honour World Mental Health Day 2024 and support our mission of increasing awareness and understanding of anxiety.   Watch the video and visit our website to find out more about the initiative: https://lnkd.in/ebVxG6pc By sharing and engaging with this video, you can help raise awareness and provide valuable support to those affected by anxiety. Together, we can make a significant impact. #mentalhealthawareness #PeaceOfMind #MentalHealth #Anxiety #CNS #Neuraxpharm

Neuraxpharm is proud to have participated in CPHI Milan 2024. Over three dynamic days, our teams from International Business, Business Development, Supplier management, and colleagues from other departments had the chance to engage with more than 100 companies, exchanging insights and exploring cutting-edge advances in the pharmaceutical industry. The event provided an excellent platform to strengthen relationships, explore business opportunities, and discuss future collaborations. A huge thank you to our partners and everyone we connected with at CPHI. Your collaboration drives our continuous growth and reinforces our commitment to delivering impactful solutions to patients. We look forward to bringing these exciting ideas to life and continuing to expand our CNS footprint, where we prioritize patients’ needs and improve their access to better treatments. See you next year CPHI! #CPHI #CPHIMilan #pharma #Neuraxpharm

Join us on World Mental Health Day as we launch our campaign, Peace of Mind - Overcoming Anxiety. Developed in partnership with Maudsley Learning, our campaign aims to raise awareness and understanding of anxiety, a condition that affects millions globally.   As part of this initiative, we are proud to present a special film that dives deep into the experiences of individuals living with anxiety. Watch our film and join the conversation.   This campaign also features a series of insightful videos where psychiatrists offer practical advice for patients and caregivers, helping to navigate the complexities of anxiety. Visit our website to find out more about the initiative: https://lnkd.in/ebVxG6pc Your support is crucial in spreading awareness and fostering a compassionate and informed community.   Together, we can make a difference. Thank you for your support! #WorldMentalHealthDay #mentalhealthawareness #MentalHealth #Anxiety #CNS #Neuraxpharm

Neuraxpharm will be attending CPHI Milan next week from 8th-10th October. Our teams from International Business and Business Development, together with other departments, will be there.   CPHI offers unparalleled opportunities to expand business horizons and forge connections at the core of the #pharmaceutical sector. We look forward to meeting with our 100+ global partners, strengthening relationships and exploring new opportunities.   Neuraxpharm is committed to innovation, expanding our #CNS footprint and enhancing our global growth in the pharmaceutical industry.   We look forward to seeing you in Milan!   #CPHI #CPHIMilan #pharma #neurology

Should personal relationships be different for people affected by epilepsy?  In this testimonial video developed by Neuraxpharm in partnership with Young Epilepsy, young people with epilepsy share their concerns and experiences on how epilepsy might have affected their personal relationships.  It is important to ask any questions to a healthcare professional about the effect of epilepsy on relationships and how to stay safe.  By understanding the concerns and experiences from people with epilepsy, we aim to create more empathy and support to develop good relationships and encourage good communication.       #Epilepsy #Neuraxpharm #YoungEpilepsy #relationships #stigma

We are thrilled to share the success of Neuraxpharm's partnership with Maudsley Learning in providing the “Maudsley Addictions Symposium 2024” tailored for professionals across various disciplines who engage with patients facing addiction challenges. Esteemed experts from South London and Maudsley, along with the Institute of Psychiatry, Psychology, and Neuroscience, delivered cutting-edge insights into addiction treatment. Topics covered from innovative harm reduction strategies to non-pharmacological interventions.   This impactful event brought together healthcare professionals, both online and on demand, to explore the latest advancements in addiction treatment. At Neuraxpharm, we remain deeply committed to medical education and advancing Central Nervous System care. Our collaboration with Maudsley Learning underscores our dedication to improving patient outcomes through cutting-edge research and clinical practice.   Together, we continue to strive towards enhancing the quality of care for patients worldwide.   #MedicalEducation #CNS #Addictions #Neuraxpharm #HealthcareInnovation #PatientCare

Today #Neuraxpharm announces the launch of Neuraxpharm Middle East. We continue our international expansion to bring leading CNS products, including a prescription brand indicated for the treatment of adult patients with relapsing multiple sclerosis (RMS), to new territories. Neuraxpharm expands its operations to cover the six members of the Gulf Cooperation Council (GCC) – the Kingdom of Saudi Arabia, United Arab Emirates, Bahrain, Kuwait, Oman and Qatar.   This exciting news follows the opening of Neuraxpharm affiliates in Brazil and Mexico in 2023 and adds to the growing list of more than 20 European countries where the Company is now established alongside its global network of distributors.   Find out more about this expansion and Neuraxpharm Middle East's base in Dubai in the press release linked below.   #CNS #MultipleSclerosis #pharma #pharmaceutical

October is Attention Deficit Hyperactivity Disorder (#ADHD) Awareness Month. This neurodevelopmental disorder develops in childhood and can continue into adulthood, affecting individuals across generations.   ADHD affects daily life, school and work and is characterized by symptoms of inattentiveness, hyperactivity, and impulsiveness. Children affected by ADHD and their parents can be given educational and wider support, advice, and guidance, alongside medical and behavioural therapies, to help them manage the symptoms of the condition.   A delayed diagnosis can cause unnecessary burden for those affected, which could be reduced with earlier diagnosis and treatment. At Neuraxpharm, we are committed to improving the quality of life and mental wellbeing of people living with CNS disorders.    Share this post and help us raise awareness about ADHD.   #Neuraxpharm #AwarenessIsKey #AwarenessOctober #ADHD #ADHDMonth #ADHDAwareness #Neurology

At the Italian Society of Paediatric and Adolescent Neuropsychiatry (SINPIA) National Congress, held in Verona on Friday 20th September 2024 and dedicated to young neuro-psychiatrists, over 150 physicians attended a lecture sponsored by #Neuraxpharm Italy. The lecture discussed the therapeutic management of paediatric status epilepticus and paediatric prolonged convulsive seizures.   #CNS #neurology #pharmaceuticals #pharma

This week, Neuraxpharm had the great pleasure of attending the 40th joint ECTRIMS congress (European Committee for Treatment and Research in Multiple Sclerosis) in Copenhagen with our partner TG Therapeutics, Inc.. ECTRIMS is the world’s largest Multiple Sclerosis meeting, and this year brought together around 9,000 neurologists and MS experts from more than 100 countries.   The Neuraxpharm team had the opportunity to connect face to face with the global MS community and showcase our initiatives to support those living with MS. Neuraxpharm and TG Therapeutics were present with a large scientific booth featuring the latest information on our MS therapy and interesting booth talks delivered by leading MS experts generated high interest among neurologists. In addition, new scientific data on the treatment of MS was presented by our partner TG Therapeutics.   As a leading European pharmaceutical company focused on the central nervous system, Neuraxpharm is fully committed to improving the quality of life of people living with #MultipleSclerosis.   #ECTRIMS2024 #MultipleSclerosis #MS #Neurology